41 filings
8-K
SPRY
ARS Pharmaceuticals Inc
10 May 24
Regulation FD Disclosure
7:01am
8-K
SPRY
ARS Pharmaceuticals Inc
9 May 24
ARS Pharmaceuticals Highlights neffy Regulatory Progress and Reports First Quarter 2024 Financial Results
4:08pm
8-K
SPRY
ARS Pharmaceuticals Inc
21 Mar 24
ARS Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
4:06pm
8-K
SPRY
ARS Pharmaceuticals Inc
7 Mar 24
Results of Operations and Financial Condition
12:56pm
8-K
SPRY
ARS Pharmaceuticals Inc
9 Nov 23
ARS Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Updates
4:02pm
8-K
ylk gr6d0n8
25 Sep 23
Regulation FD Disclosure
4:17pm
8-K
da2ea7z8a mlly
20 Sep 23
Other Events
6:05am
8-K
4dhgt
10 Aug 23
ARS Reports Second Quarter 2023 Financial Results and Provides Business Updates
4:05pm
8-K
8bu4dc r3w795dljkn
28 Jun 23
Submission of Matters to a Vote of Security Holders
4:32pm
8-K
3tpnitwp0dp0k
16 May 23
Regulation FD Disclosure
4:31pm
8-K
3yxww5950
15 May 23
ARS Pharmaceuticals Highlights Progress and Reports First Quarter 2023 Financial Results
9:03am
8-K
gq8q2sslm4oxehmx3z
9 May 23
Regulation FD Disclosure
9:12am
8-K
0gjl65szd1w84 llyhs
23 Mar 23
ARS Pharmaceuticals Highlights Progress and Reports Fourth Quarter and Full Year 2022 Financial Results
4:09pm
8-K
liofr kb7
13 Mar 23
Regulation FD Disclosure
9:26am
8-K
co96d
22 Feb 23
Entry into a Material Definitive Agreement
4:11pm
8-K
jqjp41u486m6dldvyh
14 Feb 23
Results of Operations and Financial Condition
6:12am
8-K/A
upgf2u3cvrpo
17 Jan 23
Report of Independent Registered Public Accounting Firm
5:06pm
8-K
cihczxf
9 Dec 22
Departure of Directors or Certain Officers
5:02pm
8-K
vo8a1339 n2
6 Dec 22
Regulation FD Disclosure
5:07pm
8-K
bvi t99zqsd15phrgy
8 Nov 22
ARS Pharmaceuticals Closes Merger with Silverback Therapeutics
4:51pm